To examine whether respiratory LPS exposure indeed increased vaccine-induced antigen-specific airway luminal T cells via enhancing peripheral T cell recruitment, we employed an approach that we used previously [8] by which FTY720, a sphingosine 1-phosphate receptor modulator, was injected to induce peripheral lymphopenia and block lymphocyte trafficking. This evidence concerns the gene S1PR1 and lymphopenia.